Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Anticancer Research

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 25750287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro efficacy of cinnarizine against lymphoma and multiple myeloma.

  2015cited by this paper
• Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta‐catenin pathway

  2014cited by this paper
• Effect of Wnt inhibitors in pancreatic cancer.

  2014cited by this paper
• Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.

  2014cited by this paper
• Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.

  2013cited by this paper
• Targeting the Wnt/beta-catenin pathway in multiple myeloma.

  2013cited by this paper
• Flunarizine

  2012cited by this paper
• In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma.

  2012cited by this paper
• Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

  2012cited by this paper
• Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma

  2012cited by this paper
• Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.

  2011cited by this paper
• Increased in vivo efficacy of lenalidomide by addition of piroctone olamine.

  2011cited by this paper
• Influencing the Wnt signaling pathway in multiple myeloma.

  2011cited by this paper
• Initial genome sequencing and analysis of multiple myeloma

  2011cited by this paper
• Multiple myeloma.

  2011cited by this paper
• Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid.

  2011cited by this paper
• The Ca2+ channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells

  2010cited by this paper
• Autologous hematopoietic stem-cell transplantation for multiple myeloma.

  2009cited by this paper
• β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model

  2009cited by this paper
• Targeting Wnt pathway in lymphoma and myeloma cells

  2009cited by this paper
• Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway

  2009cited by this paper
• Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression.

  2009cited by this paper
• A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.

  2008cited by this paper
• Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

  2007cited by this paper
• Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.

  2007cited by this paper
• Wnt/beta-catenin signaling in development and disease.

  2006cited by this paper
• Wnt signaling: is the party in the nucleus?

  2006cited by this paper
• Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol.

  2006cited by this paper
• Investigational treatments for multiple myeloma

  2006cited by this paper
• Wnt signaling in disease and in development

  2005cited by this paper
• WNT and β-catenin signalling: diseases and therapies

  2004cited by this paper
• Illegitimate WNT signaling promotes proliferation of multiple myeloma cells.

  2004cited by this paper
• Wnt signaling in B-cell neoplasia

  2003cited by this paper
• Voltage-gated sodium ion channels in prostate cancer: expression and activity.

  2002cited by this paper
• Multiple myeloma: evolving genetic events and host interactions

  2002cited by this paper
• Wnt signaling and cancer.

  2000cited by this paper
• β‐catenin is a target for the ubiquitin–proteasome pathway

  1997cited by this paper
• beta-catenin is a target for the ubiquitin-proteasome pathway.

  1997cited by this paper
• Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma.

  1995cited by this paper
• Flunarizine as a modulator of doxorubicin resistance in human colon‐adenocarcinoma cells

  1993cited by this paper
• Inhibition of melanoma cell directional migration in vitro via different cellular targets

  1993cited by this paper
• Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas.

  1990cited by this paper
• In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine.

  1987cited by this paper
• Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells.

  1984cited by this paper
• Multiple myeloma.

  1948cited by this paper

• Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition

  2023cites this paper
• Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs [version 1; peer review: 2 approved]

  2022cites this paper
• Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis

  2022cites this paper
• Flunarizine suppresses Mycobacterium tuberculosis growth via calmodulin‐dependent phagosome maturation

  2021cites this paper
• Pharmacological interventions part II

  2020cites this paper
• Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells

  2020cites this paper
• Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

  2020cites this paper
• Flunarizine, a drug approved for treating migraine and vertigo, exhibits cytotoxicity in GBM cells.

  2020cites this paper
• Small molecules bind human mTOR protein and inhibit mTORC1 specifically

  2018cites this paper
• Ethacrynic Acid and Ciclopiroxolamine in Various Cancer Cells

  2018cites this paper
• In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma.

  2017cites this paper
• Griseofulvin Efficiently Induces Apoptosis in In Vitro Treatment of Lymphoma and Multiple Myeloma.

  2017cites this paper
• Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma.

  2016cites this paper
• Clofibrate Demonstrates Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma.

  2016cites this paper
• Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs

  2015cites this paper
• In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma.

  2015cites this paper